ClinicalTrials.Veeva

Menu

Probiotics as a Prophylaxis to Prevent Clinical Manifestations of Oral Candidosis in Patients With Sjogren's Syndrome

Cairo University (CU) logo

Cairo University (CU)

Status and phase

Completed
Phase 2
Phase 1

Conditions

Sjogren's Syndrome

Treatments

Drug: Probiotic Product - Cap

Study type

Interventional

Funder types

Other

Identifiers

NCT03840538
20112012

Details and patient eligibility

About

Sjogren's syndrome is an autoimmune chronic disease. It has two forms Primary Sjogren's syndrome charactrized by dry eyes and dry mouth. Secondary Sjogren's syndrome characterized by rheumatoid diseases as rheumatoid arthritis, scleroderma and lupus erythematosus. SS patients are most liable to oral candidiasis , so they need prophylaxis aganist oral candidiasis. Probiotic bacteria are live microorganisms that when administered in adequate amounts confer benefits to health.Probiotics are commonly used as a prophylaxis aganist oral candidosis.

Enrollment

32 patients

Sex

All

Ages

30 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • primary or scondary Sjogren's syndrome

Exclusion criteria

  • allergy to milk derivatives previous intake of antifungals

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

32 participants in 2 patient groups, including a placebo group

Probiotic group
Experimental group
Description:
Probiotic complex capsule taken twice daily for 5weeks
Treatment:
Drug: Probiotic Product - Cap
Placebo group
Placebo Comparator group
Description:
Placebo capsule taken twice daily for 5 weeks
Treatment:
Drug: Probiotic Product - Cap

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems